REBECCA ADAMS: Open Payments
NPI 1700403599 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 6 payments from 4 companies in 2025. Trend: 2023 $54 · 2024 $228 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 1 | $122 |
| GENZYME CORPORATION | 3 | $111 |
| Smith+Nephew, Inc. | 1 | $59 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
Products named: DUPIXENT, Xhance, TULA.
Industry payments across GA — which companies pay providers there.
